Novel-Protein Allergy Documentation Reaches Mainstream Retail
Documented novel-protein allergy-management evidence, which carries measured elimination-diet outcomes rather than the generic exotic-protein marketing claims that historically dominated the venison pet food aisle, has moved from a veterinary-only recommendation into mainstream specialty retail adoption since 2023 as testing costs declined enough to reach broader supplier budgets. This documented evidence addresses a genuine allergy-verification demand that generic exotic-protein claims alone could never satisfy as directly across most allergy-conscious owners. Suppliers now formulate products specifically validated against measurable elimination-diet outcomes rather than generic novelty claims alone. Retailers now expect this evidence before approving new shelf placements.
Market Impact: Adds 17% more humanization-driven demand








